Intervention

acetylsalicylic acid

ClinicalTrials.gov intervention label

Clinical trials9

Recruiting0

Common conditions17

Lead sponsors shown9

Clinical trials

9 shown

Low Doses of Aspirin in the Prevention of PreeclampsiaNCT04070573 · 2019-10-21

Efficacy of Aspirin and L-arginine in High Risk PreeclampticNCT02838030 · 2018-07-01

Antiplatlet Effects of Standardized Tomato Extract in Hypertensive SubjectsNCT03206944 · 2015-07-01

Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple SclerosisNCT02090413 · 2014-05-01

Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerNCT01707823 · 2012-10-01

Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective DisorderNCT01320982 · 2011-03-01

Laboratory Aspirin Resistance in Diabetics and Non-DiabeticsNCT00563875 · 2007-11-01

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate CancerNCT00316927 · 2002-12-01

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of RelapseNCT00055731 · 2002-11-14

Common conditions

Prostate Cancer2 Adenocarcinoma of the Lung1 Drug Resistance1 High Risk Pregnancy1 Hypertension,Essential1 Obesity1 Preeclampsia1 Recurrent Non-small Cell Lung Cancer1 Relapsing-Remitting Multiple Sclerosis1 Schizoaffective Disorder1 Schizophrenia1 Stage IA Non-small Cell Lung Cancer1 Stage IB Non-small Cell Lung Cancer1 Stage IIA Non-small Cell Lung Cancer1 Stage IIB Non-small Cell Lung Cancer1 Stage IIIA Non-small Cell Lung Cancer1 Stage IIIB Non-small Cell Lung Cancer1

Leading sponsors

Beata Krasinska1 Biogen1 Sheba Medical Center1 St. Bartholomew's Hospital1 UNICANCER1 University of Aarhus1 University of Guadalajara1 Vanderbilt-Ingram Cancer Center1 Weill Medical College of Cornell University1

Trial status mix

COMPLETED6

SUSPENDED1

TERMINATED1

UNKNOWN1

Phase mix

PHASE34

PHASE42

EARLY_PHASE11

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.